Evidence map›Paper›PMID 35428497›Full record

ArticleVaccine2022

Dashboard development for near real-time visualization of COVID-19 vaccine safety surveillance data in the vaccine safety datalink.

Tat'Yana A Kenigsberg, Anne M Hause, Michael M McNeil, Jennifer C Nelson, Jo Ann Shoup, Kristin Goddard, Yingbo Lou, Kayla E Hanson, Sungching C Glenn, Eric S Weintraub

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Vaccine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. COVID-19 Vaccines and the Virus: Impact on Drug Metabolism and Pharmacokinetics.Drug metabolism and disposition: the biological fate of chemicals · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Tat'Yana A KenigsbergCenters for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: ynf1@cdc.gov.
Anne M HauseCenters for Disease Control and Prevention, Atlanta, GA, USA.
Michael M McNeilCenters for Disease Control and Prevention, Atlanta, GA, USA.
Jennifer C NelsonKaiser Permanente Washington Research Institute, Seattle, WA, USA.
Jo Ann ShoupInstitute for Health Research, Kaiser Permanente, Denver, CO, USA.
Kristin GoddardKaiser Permanente Northern California, Oakland, CA, USA.
Yingbo LouDenver Health, Denver, CO, USA.
Kayla E HansonMarshfield Clinic Research Institute, Marshfield, WI, USA.
Sungching C GlennKaiser Permanente Southern California, Pasadena, CA, USA.
Eric S WeintraubCenters for Disease Control and Prevention, Atlanta, GA, USA.
Centers for Disease Control and Prevention · USKaiser Permanente · USKaiser Permanente Washington Health Research Institute · USMarshfield Clinic · USUniversity of Colorado Denver · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Vaccine Safety Datalink (VSD) conducts active surveillance and vaccine safety research studies. Since the start of the U.S. COVID-19 vaccination program, the VSD has conducted near real-time safety surveillance of COVID-19 vaccines using Rapid Cycle Analysis. VSD investigators developed an internal dashboard to facilitate visualization and rapid reviews of large weekly automated vaccine safety surveillance data. Dashboard development and maintenance was informed by vaccine surveillance data users and vaccine safety partners. Key metrics include population demographics, vaccine uptake, pre-specified safety outcomes, sequential analyses results, and descriptive data on potential vaccine safety signals. Dashboard visualizations are used to provide situational awareness on dynamic vaccination coverage and the status of multiple safety analyses conducted among the VSD population. This report describes the development and implementation of the internal VSD COVID-19 Vaccine Dashboard, including metrics used to develop the dashboard, which may have application across various other public health settings.

Indexed as

COVID-19VaccinesCOVID-19 VaccinesHumansVaccinationCOVID-19 VaccinesVaccinesData visualizationPublic health surveillanceVaccines

Identifiers

PMID35428497
PMCPMC8989890
OpenAlexW4223977837

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.